Evaluating the impact of heterogeneity of prevalence and incidence in malaria cluster randomised control trials: Can trials be designed more efficiently?.
2022
(2022).
2022
Diseases (Basel, Switzerland), (2022).10 4 10.3390/diseases10040101.
2022
International Journal of Infectious Diseases (IJID), (2022).125, 10.1016/j.ijid.2022.10.043.
2022
Cochrane Database of Systematic Reviews, (2022).2022 11 10.1002/14651858.cd015128.
2022
International Journal of Mosquito Research, (2022).9 6 10.22271/23487941.2022.v9.i6a.639.
2022
International Journal of Mosquito Research, (2022).9 6 10.22271/23487941.2022.v9.i6b.653.
2022
The Lancet Infectious diseases, (2022).23 3 10.1016/S1473-3099(22)00593-X.
Overall and gender-specific effects of intermittent preventive treatment of malaria with artemisinin-based combination therapies among schoolchildren in Mali: a three-group open label randomized controlled trial.
2022
American Journal of Tropical Medicine and Hygiene, (2022).107 4
Prevalence of sulfadoxine-pyrimethamine resistance markers of Plasmodium falciparum among pregnant women in an area of high malaria transmission: Nchelenge, Zambia.
2022
(2022).(4) 1422 107
Overall and gender-specific effects of intermittent preventive treatment of malaria with artemisinin-based combination therapies among schoolchildren in Mali: a three-group open label randomized controlled trial.
2022
(2022).(4) 0901 107
